SCHEMBL9587136

SCHEMBL9587136

CCOC(=O)CC(c1ccccn1)c1occ2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GAA P10253 1/20 0.44
LMNA P02545 1/20 0.41
ALDH1A1 P00352 5/20 0.39
CYP1A2 P05177 1/20 0.39
CASP1 P29466 1/20 0.38
KDM4E B2RXH2 3/20 0.38
MAPT P10636 1/20 0.38
TOP2A P11388 1/20 0.38
ELANE P08246 2/20 0.38
PRNP P04156 2/20 0.38
RXFP1 Q9HBX9 2/20 0.38
TSHR P16473 1/20 0.38
HPGD P15428 2/20 0.37
HTT P42858 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9587127 0.77 MEN1 (0.46) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL657973 0.74 KMT2A (0.38) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL313449 0.73 SMN1; SMN2 (0.56) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL5929583 0.73 SMN1; SMN2 (0.56) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL1077616 0.72 SMN1; SMN2 (0.55) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL1051991 0.72 SMN1; SMN2 (0.55) MEN1KMT2ASMN1; SMN2GAALMNA
Hydrochloric Acid SCHEMBL5742023 0.71 SMN1; SMN2 (0.53) MEN1KMT2ASMN1; SMN2GAALMNA
Hydrochloric Acid SCHEMBL7321879 0.71 SMN1; SMN2 (0.53) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL9097352 0.71 GAA (0.39) MEN1KMT2ASMN1; SMN2GAALMNA
SCHEMBL7548098 0.71 SMN1; SMN2 (0.47) MEN1KMT2ASMN1; SMN2GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5262430-A Antidiabetic agent lowers blood glucose in mammals in type 2 non insulin dependent diabetes NOVO NORDISK A/S (DK) 1993-11-16 US disclosed